MedTrace Logo

D1 Receptor Occupancy (RO) Following a Single Dose of PF-06412562

NCT03686501 · Status: COMPLETED · Phase: EARLY_PHASE1 · Type: INTERVENTIONAL · Enrollment: 6

Last updated 2019-04-22

No results posted yet for this study

Summary

To assess the D1 receptor occupancy (D1 RO) in striatum after a single oral administration of PF-06412562.

Conditions

  • Healthy Male Volunteers

Interventions

DRUG

PF-06412562

Healthy Volunteers recruited for the study will undergo a single dose of PF-06412562 and will undergo two \[18F\]MNI-968 injections

Sponsors & Collaborators

  • Invicro

    lead OTHER

Study Design

Allocation
NA
Purpose
OTHER
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
20 Years
Max Age
55 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-09-10
Primary Completion
2019-03-28
Completion
2019-03-28
FDA Drug
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03686501 on ClinicalTrials.gov